<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医药魔方Pro | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-01T23:13:08+08:00</updated>
  <subtitle>聚焦生物医药前沿，洞察研发投资风向</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>贾为国点评 | 下一代溶瘤病毒开发：主攻三大方向</title>
    <updated>2020-12-01T20:59:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/a1uEQKlCEgCE7tz8mNy6Hw</id>
    <link href="https://mp.weixin.qq.com/s/a1uEQKlCEgCE7tz8mNy6Hw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Cell：癌症免疫治疗新靶点——SerpinB9</title>
    <updated>2020-11-30T20:59:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-30:/s/H3bRPtFNakrgSnZHtzFDJA</id>
    <link href="https://mp.weixin.qq.com/s/H3bRPtFNakrgSnZHtzFDJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺奖之后，基因疗法有多热？</title>
    <updated>2020-11-29T20:58:46+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/rbcM3vy_OF6fs4VQVWF6BA</id>
    <link href="https://mp.weixin.qq.com/s/rbcM3vy_OF6fs4VQVWF6BA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>再生医学重大突破！新药诱导干细胞精准定位，有望改进多种疾病干细胞疗法 | PNAS最新成果</title>
    <updated>2020-11-28T20:58:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-28:/s/CBp0eP4wUzaHvsIONLPbTw</id>
    <link href="https://mp.weixin.qq.com/s/CBp0eP4wUzaHvsIONLPbTw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PNAS最新成果：癌症免疫疗法新兵——MARCO抗体</title>
    <updated>2020-11-27T21:00:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/RBvGL8BltEHZZ0wau96Q1g</id>
    <link href="https://mp.weixin.qq.com/s/RBvGL8BltEHZZ0wau96Q1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“现货型”CAR-NK疗法又添新玩家！这家刚获4200万美元融资的新锐公司有何独特技术？</title>
    <updated>2020-11-26T20:58:15+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/U1ibxOrEX5JGMSK6YvJrUw</id>
    <link href="https://mp.weixin.qq.com/s/U1ibxOrEX5JGMSK6YvJrUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>巨噬细胞疗法，向着实体瘤出发</title>
    <updated>2020-11-25T21:00:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/Sf1u8b6CtPjv6uxH72V3LQ</id>
    <link href="https://mp.weixin.qq.com/s/Sf1u8b6CtPjv6uxH72V3LQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿尔茨海默症新靶点——MCL-1</title>
    <updated>2020-11-24T20:58:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/U7LD1u_Aj7pXlpTmlg0EYg</id>
    <link href="https://mp.weixin.qq.com/s/U7LD1u_Aj7pXlpTmlg0EYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>总生存率最高提升至80%！CRISPR抗癌获突破：新型给药系统安全有效，体内编辑率高达80% | Science子刊</title>
    <updated>2020-11-23T20:58:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/6vzDNCBdhnXbqEINKC_irA</id>
    <link href="https://mp.weixin.qq.com/s/6vzDNCBdhnXbqEINKC_irA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>胰腺癌新靶点——NetG1</title>
    <updated>2020-11-22T21:00:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-22:/s/robqQfFehFVuiZmjiq3Vjw</id>
    <link href="https://mp.weixin.qq.com/s/robqQfFehFVuiZmjiq3Vjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>